Back to UBS Group AG UBS Group AG

RNAZRNAZ
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in TRANSCODE THERAPEUTICS INC

UBS Group AG holds 2,888 shares of RNAZ (TRANSCODE THERAPEUTICS INC), worth $17,934 as of 2026-Q2. The position was decreased (-65.2% shares).

Current Value

$17,934

Current Shares

2,888

Total Value Change

+$6,764

Total Shares Change

+1,456

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2,888
-65.2%
$17,9340.0%$6.21
0
2026-Q1
Increased
8,295
+179.9%
$71,4200.0%$10.25
23
2025-Q4
New
2,964
-
$20,2450.0%$6.44
29
2025-Q3
Exited
0
-100.0%
$00.0%$10.65
0
2025-Q2
New
1,432
-
$11,1700.0%$7.97
27

Other major holders of RNAZ: GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD FIDUCIARY TRUST CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used